Klinische Aspekte von Placebo

Ein Physiotherapeut kann seine Behandlung erfolgreicher gestalten, wenn er beim Patienten gezielt Placeboreaktionen auslöst. Wichtig für dieses Add-On zur Standardbehandlung ist das Zusammenspiel von Soft Skills, beruflichen Qualifikationen des Therapeuten und dem Therapiesetting, welches die Erwartungen der Patienten beeinflusst. Die klinische Forschung zeigt, dass das empathische und kompetente Auftreten, die wertschätzende Kommunikation und das Berücksichtigen individueller Bedürfnisse, Vorerfahrungen und Erwartungen eines Patienten dessen Behandlung positiv beeinflussen können.

Publication History

Article published online:
21 October 2020

• Literatur

• 1 Benedetti F. Placebo effects: from the neurobiological paradigm to translational implications. Neuron 2014; 84: 623-637 doi:10.1016/j.neuron.2014.10.023
• 2 Colloca L, Miller FG. Harnessing the placebo effect: the need for translational research. Philosophical transactions of the Royal Society of London Series B, Biological sciences 2011; 366: 1922-1930 doi:10.1098/rstb.2010.0399
• 3 Enck P, Bingel U, Schedlowski M. et al. The placebo response in medicine: minimize, maximize or personalize?. Nature reviews Drug discovery 2013; 12: 191-204 doi:10.1038/nrd3923
• 4 Kaptchuk TJ, Miller FG. Placebo Effects in Medicine. The New England journal of medicine 2015; 373: 8-9 doi:10.1056/NEJMp1504023
• 5 Schedlowski M, Enck P, Rief W. et al. Neuro-Bio-Behavioral Mechanisms of Placebo and Nocebo Responses: Implications for Clinical Trials and Clinical Practice. Pharmacol Rev 2015; 67: 697-730 doi:10.1124/pr.114.009423
• 6 Crum A, Zuckerman B. Changing Mindsets to Enhance Treatment Effectiveness. JAMA 2017; 317: 2063-2064 doi:10.1001/jama.2017.4545
• 7 Hadamitzky M, Sondermann W, Benson S. et al. Placebo effects in the immune system. Int Rev Neurobiol 2018; 138: 39-59 doi:10.1016/bs.irn.2018.01.001
• 8 Moseley JB, OʼMalley K, Petersen NJ. et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. The New England journal of medicine 2002; 347: 81-88 doi:10.1056/NEJMoa013259
• 9 Tomlinson CL, Patel S, Meek C. et al. Physiotherapy versus placebo or no intervention in Parkinsonʼs disease. Cochrane Database System Rev 2013; CD002817
• 10 Colloca L, Finniss D. Nocebo Effects, Patient-Clinician Communication, and Therapeutic Outcomes. Jama-J Am Med Assoc 2012; 307: 567-568 doi:10.1001/jama.2012.115
• 11 Bingel U, Placebo Competence T. Avoiding nocebo effects to optimize treatment outcome. JAMA 2014; 312: 693-694 doi:10.1001/jama.2014.8342
• 12 Schmitz J, Müller M, Stork J. et al. Positive Treatment Expectancies Reduce Clinical Pain and Perceived Limitations in Movement Ability Despite Increased Experimental Pain: A Randomized Controlled Trial on Sham Opioid Infusion in Patients with Chronic Back Pain. Psychotherapy and Psychosomatics 2019; 88: 203-214 doi:10.1159/000501385
• 13 Colloca L, Barsky AJ. Placebo and Nocebo Effects. The New England journal of medicine 2020; 382: 554-561 doi:10.1056/NEJMra1907805
• 14 Goebel MU, Trebst AE, Steiner J. et al. Behavioral conditioning of immunosuppression is possible in humans. Faseb J 2002; 16: 1869-1873 doi:10.1096/fj.02-0389com
• 15 Kirchhof J, Petrakova L, Brinkhoff A. et al. Learned immunosuppressive placebo responses in renal transplant patients. Proceedings of the National Academy of Sciences of the United States of America 2018; 115: 4223-4227 doi:10.1073/pnas.1720548115
• 16 Meissner K. Placebo responses on cardiovascular, gastrointestinal, and respiratory organ functions. Handb Exp Pharmacol 2014; 225: 183-203 doi:10.1007/978-3-662-44519-8_11
• 17 Park C, Pagnini F, Reece A. et al. Blood sugar level follows perceived time rather than actual time in people with type 2 diabetes. Proceedings of the National Academy of Sciences of the United States of America 2016; 113: 8168-8170 doi:10.1073/pnas.1603444113
• 18 Klinger R, Colloca L, Bingel U. et al. Placebo analgesia: clinical applications. Pain 2014; 155: 1055-1058 doi:10.1016/j.pain.2013.12.007
• 19 Berry DC, Broadbent DE. Interactive tasks and the implicit-explicit distinction. British Journal of Psychology 1988; 79: 251-272 doi:10.1111/j.2044-8295.1988.tb02286.x
• 20 Jensen KB, Kaptchuk TJ, Chen X. et al. A Neural Mechanism for Nonconscious Activation of Conditioned Placebo and Nocebo Responses. Cereb Cortex 2015; 25: 3903-3910 doi:10.1093/cercor/bhu275
• 21 Jensen KB, Kaptchuk TJ, Kirsch I. et al. Nonconscious activation of placebo and nocebo pain responses. Proceedings of the National Academy of Sciences of the United States of America 2012; 109: 15959-15964 doi:10.1073/pnas.1202056109
• 22 Colloca L, Sigaudo M, Benedetti F. The role of learning in nocebo and placebo effects. Pain 2008; 136: 211-218 doi:10.1016/j.pain.2008.02.006
• 23 Colloca L, Benedetti F. Placebo analgesia induced by social observational learning. Pain 2009; 144: 28-34 doi:10.1016/j.pain.2009.01.033
• 24 Koban L, Jepma M, Lopez-Sola M. et al. Different brain networks mediate the effects of social and conditioned expectations on pain. Nat Commun 2019; 10: 4096 doi:10.1038/s41467-019-11934-y
• 25 Vogtle E, Barke A, Kroner-Herwig B. Nocebo hyperalgesia induced by social observational learning. Pain 2013; 154: 1427-1433 doi:10.1016/j.pain.2013.04.041
• 26 Zhang H, Zhou L, Wei H. et al. The sustained influence of prior experience induced by social observation on placebo and nocebo responses. J Pain Res 2017; 10: 2769-2780 doi:10.2147/JPR.S147970
• 27 Bingel U, Colloca L, Vase L. Mechanisms and clinical implications of the placebo effect: is there a potential for the elderly? A mini-review. Gerontology 2011; 57: 354-363 doi:10.1159/000322090
• 28 Kam-Hansen S, Jakubowski M, Kelley JM. et al. Altered placebo and drug labeling changes the outcome of episodic migraine attacks. Sci Transl Med 2014; 6
• 29 Klinger R, Blasini M, Schmitz J. et al. Nocebo effects in clinical studies: hints for pain therapy. Pain reports 2017; 2
• 30 Ulrich RS. View through a Window May Influence Recovery from Surgery. Science 1984; 224: 420-421 doi:10.1126/science.6143402
• 31 Meissner K, Fassler M, Rucker G. et al. Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis. JAMA Intern Med 2013; 173: 1941-1951 doi:10.1001/jamainternmed.2013.10391
• 32 Rohsenow DJ, Marlatt GA. The balanced placebo design: methodological considerations. Addict Behav 1981; 6: 107-122 doi:10.1016/0306-4603(81)90003-4
• 33 Benedetti F. Placebo analgesia. Neurol Sci 2006; 27: 100-102 doi:10.1007/s10072-006-0580-4
• 34 Colloca L, Benedetti F. Placebos and painkillers: is mind as real as matter?. Nature Reviews Neuroscience 2005; 6: 545-552 doi:10.1038/nrn1705
• 35 Klinger R, Soost S, Flor H. et al. Classical conditioning and expectancy in placebo hypoalgesia: a randomized controlled study in patients with atopic dermatitis and persons with healthy skin. Pain 2007; 128: 31-39 doi:10.1016/j.pain.2006.08.025
• 36 Miller FG, Colloca L. The legitimacy of placebo treatments in clinical practice: evidence and ethics. Am J Bioeth 2009; 9: 39-47 doi:10.1080/15265160903316263
• 37 Deutsche Interdisziplinäre Vereinigung für Schmerztherapie DIV. S3-Leitlinie Behandlung akuter perioperativer und posttraumatischer Schmerzen. (AWMF-Register Nr. 041/001). Stand: 21.05.2007 inkl. Änderungen vom 20. 04. 2009. Im Internet (Stand: 09.07.2020): https://www.dgni.de/images/stories/Leitlinien/behandlung_akuter_perioperativer_und_posttraumatischer_schmerzen.pdf
• 38 Blease C, Colloca L, Kaptchuk TJ. Are open-Label Placebos Ethical? Informed Consent and Ethical Equivocations. Bioethics 2016; 30: 407-414 doi:10.1111/bioe.12245
• 39 Kaptchuk TJ, Miller FG. Open label placebo: can honestly prescribed placebos evoke meaningful therapeutic benefits?. BMJ 2018; 363: k3889 doi:10.1136/bmj.k3889
• 40 Kaptchuk TJ, Friedlander E, Kelley JM. et al. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One 2010; 5: e15591 doi:10.1371/journal.pone.0015591